BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31813800)

  • 1. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
    Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
    Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors.
    Matsuzaki Y; Konno A; Mukai R; Honda F; Hirato M; Yoshimoto Y; Hirai H
    Mol Neurobiol; 2017 Apr; 54(3):1745-1758. PubMed ID: 26884266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
    Bailey RM; Rozenberg A; Gray SJ
    Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.
    Bucher T; Colle MA; Wakeling E; Dubreil L; Fyfe J; Briot-Nivard D; Maquigneau M; Raoul S; Cherel Y; Astord S; Duque S; Marais T; Voit T; Moullier P; Barkats M; Joussemet B
    Hum Gene Ther; 2013 Jul; 24(7):670-82. PubMed ID: 23799774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9.
    Chatterjee D; Marmion DJ; McBride JL; Manfredsson FP; Butler D; Messer A; Kordower JH
    Gene Ther; 2022 Jun; 29(6):390-397. PubMed ID: 33753910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
    Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
    Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized Method for Intra-Cisterna Magna Delivery Under Fluoroscopic Guidance in Nonhuman Primates.
    Katz N; Goode T; Hinderer C; Hordeaux J; Wilson JM
    Hum Gene Ther Methods; 2018 Oct; 29(5):212-219. PubMed ID: 30032644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals.
    Hinderer C; Bell P; Katz N; Vite CH; Louboutin JP; Bote E; Yu H; Zhu Y; Casal ML; Bagel J; O'Donnell P; Wang P; Haskins ME; Goode T; Wilson JM
    Hum Gene Ther; 2018 Jan; 29(1):15-24. PubMed ID: 28806897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of Adeno-Associated Virus Gene Therapy Following Cerebrospinal Fluid-Directed Administration.
    Chen X; Lim DA; Lawlor MW; Dimmock D; Vite CH; Lester T; Tavakkoli F; Sadhu C; Prasad S; Gray SJ
    Hum Gene Ther; 2023 Feb; 34(3-4):94-111. PubMed ID: 36606687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates.
    Samaranch L; Bringas J; Pivirotto P; Sebastian WS; Forsayeth J; Bankiewicz K
    Hum Gene Ther Methods; 2016 Feb; 27(1):13-6. PubMed ID: 26757202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.
    Choudhury SR; Fitzpatrick Z; Harris AF; Maitland SA; Ferreira JS; Zhang Y; Ma S; Sharma RB; Gray-Edwards HL; Johnson JA; Johnson AK; Alonso LC; Punzo C; Wagner KR; Maguire CA; Kotin RM; Martin DR; Sena-Esteves M
    Mol Ther; 2016 Aug; 24(7):1247-57. PubMed ID: 27117222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates.
    Samaranch L; Salegio EA; San Sebastian W; Kells AP; Foust KD; Bringas JR; Lamarre C; Forsayeth J; Kaspar BK; Bankiewicz KS
    Hum Gene Ther; 2012 Apr; 23(4):382-9. PubMed ID: 22201473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early distribution of
    Kumagai S; Nakajima T; Shimazaki K; Kakiuchi T; Harada N; Ohba H; Onuki Y; Takino N; Ito M; Sato M; Nakamura S; Osaka H; Yamagata T; Kawai K; Muramatsu SI
    J Gene Med; 2023 Jan; 25(1):e3457. PubMed ID: 36278965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Infusion of AAV for Widespread Gene Delivery to the Nervous System.
    Gessler DJ; Tai PWL; Li J; Gao G
    Methods Mol Biol; 2019; 1950():143-163. PubMed ID: 30783972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection.
    Peterson CD; Skorput AGJ; Kitto KF; Wilcox GL; Vulchanova L; Fairbanks CA
    Methods Mol Biol; 2019; 1950():199-207. PubMed ID: 30783975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice.
    Davidson CD; Gibson AL; Gu T; Baxter LL; Deverman BE; Beadle K; Incao AA; Rodriguez-Gil JL; Fujiwara H; Jiang X; Chandler RJ; Ory DS; Gradinaru V; Venditti CP; Pavan WJ
    Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34407999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-cisterna magna delivery of an AAV vector with the GLUT1 promoter in a pig recapitulates the physiological expression of SLC2A1.
    Nakamura S; Osaka H; Muramatsu SI; Takino N; Ito M; Jimbo EF; Watanabe C; Hishikawa S; Nakajima T; Yamagata T
    Gene Ther; 2021 Jun; 28(6):329-338. PubMed ID: 33077933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.
    Bey K; Ciron C; Dubreil L; Deniaud J; Ledevin M; Cristini J; Blouin V; Aubourg P; Colle MA
    Gene Ther; 2017 May; 24(5):325-332. PubMed ID: 28425480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain.
    Fu H; Muenzer J; Samulski RJ; Breese G; Sifford J; Zeng X; McCarty DM
    Mol Ther; 2003 Dec; 8(6):911-7. PubMed ID: 14664793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.